From Therapy to Cancer Prevention Using HRD Testing on Patients with High-grade Ovarian Cancer
Genomic instability status (HRD testing), which is essential for making therapy choices, is useful to identify inherited ovarian cancers. Identifying these families with high cancer risk is critical for implementing targeted cancer prevention strategies.
Authors
- Marco A. Pierotti (ORCID: https://orcid.org/0000-0002-7431-8332)
- Ileana Carnevali (ORCID: https://orcid.org/0000-0002-0511-5427)
- Fausto Sessa (ORCID: https://orcid.org/0000-0002-6633-536X)
- Sara Volorio
- Susanna Ronchi
- Valeria Pensotti (ORCID: https://orcid.org/0000-0003-1076-359X)
- Stefano La Rosa (ORCID: https://orcid.org/0000-0003-1941-2403)
- Nora Sahnane (ORCID: https://orcid.org/0000-0002-6227-8628)
- Laura Libera (ORCID: https://orcid.org/0000-0003-2130-6669)
- Sofia Facchi (ORCID: https://orcid.org/0009-0003-1257-049X)
- Giorgio Formenti (ORCID: https://orcid.org/0000-0002-6059-9065)
- Maria Grazia Tibiletti (ORCID: https://orcid.org/0000-0001-8471-1229)
Institutions
- University of Insubria (IT)
- Ospedale Filippo Del Ponte Varese (IT)
- Ospedale di Circolo e Fondazione Macchi (IT)
- ATS Sardegna (Italy) (IT)
- Società Italiana di Nefrologia (IT)
- Azienda Socio Sanitaria Territoriale Lariana (IT)
- Aziende Socio Sanitarie Territoriale dei Sette Laghi
Publication Details
- Journal
- Cancer Prevention Research
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1158/1940-6207.capr-24-0474
- Citations
- 1
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- Università degli Studi dell'Insubria